Simplex Trading
ADCT icon

Simplex Trading’s ADC Therapeutics ADCT Stock Holding History

Simplex Trading’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$535 Sell
500
-200
-29% -$583 ﹤0.01% 8946
2026
Q1 		$2.63K Sell
700
-1,400
-67% -$5.52K ﹤0.01% 8266
2025
Q4 		$7.41K Sell
2,100
-20,500
-91% -$83.2K ﹤0.01% 7184
2025
Q3 		$90K Sell
22,600
-10,300
-31% -$32.5K ﹤0.01% 5864
2025
Q2 		$88K Buy
+32,900
New +$69.2K ﹤0.01% 5358
2025
Q1 		– Sell
-4,300
Closed -$8K – 8388
2024
Q4 		$8K Buy
4,300
+600
+16% +$1.57K ﹤0.01% 7296
2024
Q3 		$11K Sell
3,700
-800
-18% -$2.52K ﹤0.01% 7101
2024
Q2 		$14K Buy
4,500
+1,900
+73% +$7.55K ﹤0.01% 7155
2024
Q1 		$11K Buy
+2,600
New +$9.59K ﹤0.01% 7516
2023
Q1 		– Sell
-2,300
Closed -$8K – 8887
2022
Q4 		$8K Sell
2,300
-18,300
-89% -$73.2K ﹤0.01% 7697
2022
Q3 		$99K Buy
+20,600
New +$149K ﹤0.01% 5541
2022
Q2 		– Sell
-1,200
Closed -$17K – 9822
2022
Q1 		$17K Buy
1,200
+1,000
+500% +$15.9K ﹤0.01% 8390
2021
Q4 		$4K Sell
200
-400
-67% -$9.64K ﹤0.01% 9629
2021
Q3 		$14K Hold
600
– – ﹤0.01% 8703
2021
Q2 		$14K Buy
600
+574
+2,208% +$13.3K ﹤0.01% 8857
2021
Q1 		$63K Buy
+26
New +$753 ﹤0.01% 6327

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Simplex Trading's ADCT Position: Q2 2026 in Review

Simplex Trading opened a new position in ADC Therapeutics (ADCT) in Q2 2026: 8,197 shares worth $8.77K. The stake represents ﹤0.01% of the portfolio and ranks #7792 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ADCT as recently as Q4 2025.

Simplex Trading first reported a position in ADCT in Q3 2020 and has held it in 18 quarters since. The position peaked at $66K in Q1 2024. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Simplex Trading held 8,197 shares of ADC Therapeutics worth $8.77K as of Q2 2026.
  • ADC Therapeutics was a new Simplex Trading position in Q2 2026.
  • ADC Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7792 holding.
  • Simplex Trading first reported a position in ADC Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • Simplex Trading's ADC Therapeutics position peaked at $66K in Q1 2024.
  • 114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.